Related Experiment Video
Updated: Apr 14, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Protective role of female gender in programmed accelerated renal aging in the rat
Wioletta Pijacka1, Bethan Clifford2, Chantal Tilburgs3
1School of Physiology and Pharmacology, University of Bristol, Bristol, UK Division of Nutritional Sciences, School of Biosciences, University of Nottingham, Loughborough, UK W.Pijacka@bristol.ac.uk.
Abstract:
The aging kidney exhibits a progressive decline in glomerular filtration rate, accompanied by inflammatory and oxidative damage. We hypothesized that accelerated, age-related progression of renal injury is ovarian hormones-dependant. To address this we used an established model of developmentally programmed accelerated renal aging in the rat, superimposed by ovariectomy to assess interactions between ovarian hormones and the aging process. Under our experimental conditions, we found that kidney function worsens with age, that is GFR reduces over 18 month analyzed time-course and this was worsened by fetal exposure to maternal low-protein diet and absence of estrogen. Reduction in GFR was followed by increases in albuminuria, proteinuria, inflammatory markers, and tissue carbonyls, all suggesting inflammatory response and oxidative stress. This was associated with changes in AGTR2 expression which was greater at 18 months of age compared to earlier time points, but in MLP offspring only. Our studies show an influence of ovarian hormones on programmed accelerated renal aging and the AGTR2 across the lifespan. The main findings are that ovariectomy is a risk factor for increased aging-related renal injury and that this and oxidative damage might be related to changes in AGTR2 expression.
Insights
Ovarian hormones influence kidney aging. Ovariectomy exacerbates age-related kidney injury and oxidative damage, potentially linked to changes in angiotensin II receptor type 2 (AGTR2) expression.
Area of Science:
- Nephrology
- Endocrinology
- Aging Research
Background:
- Kidney aging is characterized by reduced glomerular filtration rate (GFR), inflammation, and oxidative stress.
- The role of ovarian hormones in the accelerated progression of age-related kidney disease is not fully understood.
Purpose of the Study:
- To investigate the influence of ovarian hormones on programmed accelerated renal aging.
- To assess the interaction between ovarian hormones and aging processes in the kidney.
- To examine changes in angiotensin II receptor type 2 (AGTR2) expression in aging kidneys.
Main Methods:
- Utilized a rat model of developmentally programmed accelerated renal aging.
- Implemented ovariectomy to study the effects of estrogen absence.
- Analyzed kidney function (GFR), albuminuria, proteinuria, inflammatory markers, and tissue carbonyls over an 18-month period.
- Measured AGTR2 gene expression.
Main Results:
- Kidney function (GFR) declined with age, worsened by fetal exposure to a maternal low-protein diet and estrogen absence.
- Reduced GFR correlated with increased albuminuria, proteinuria, inflammation, and oxidative stress (tissue carbonyls).
- AGTR2 expression increased at 18 months in offspring from mothers on a low-protein diet, but not in controls.
Conclusions:
- Ovarian hormones significantly influence programmed accelerated renal aging and AGTR2 expression throughout life.
- Ovariectomy is identified as a risk factor for increased aging-related renal injury.
- Age-related renal injury and oxidative damage may be associated with alterations in AGTR2 expression.
More Related Videos
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
07:52A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism